51
|
Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 2010; 100:619-34. [PMID: 20017157 DOI: 10.1002/jso.21364] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
The global incidence of liver cancer is greater than a million cases a year. Surgical resection where applicable is still the standard of care for these patients. Various liver-directed regional therapies have been developed in an effort to treat the vast majority of unresectable liver tumors. This article reviews the principles behind various ablation therapies currently available for malignant liver tumors and their outcomes.
Collapse
Affiliation(s)
- Srikanth Padma
- Section of Hepato-Pancreatico-Biliary Surgery, Division of GI & Minimally Invasive Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, North Carolina 28203, USA
| | | | | |
Collapse
|
52
|
Abstract
Microwave ablation is an emerging treatment option for many cancers, cardiac arrhythmias, and other medical conditions. During treatment, microwaves are applied directly to tissues to produce rapid temperature elevations sufficient to produce immediate coagulative necrosis. The engineering design criteria for each application differ, with individual consideration for factors such as desired ablation zone size, treatment duration, and procedural invasiveness. Recent technological developments in applicator cooling, power control, and system optimization for specific applications promise to increase the utilization of microwave ablation in the future. This article reviews the basic biophysics of microwave tissue heating, provides an overview of the design and operation of current equipment, and outlines areas for future research.
Collapse
|
53
|
Carrafiello G, Mangini M, Fontana F, Recaldini C, Piacentino F, Pellegrino C, Laganà D, Cuffari S, Marconi A, Fugazzola C. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol 2009; 33:367-74. [PMID: 19915901 DOI: 10.1007/s00270-009-9745-x] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/28/2009] [Accepted: 10/12/2009] [Indexed: 11/29/2022]
Abstract
The purpose of this study was to determine the safety, effectiveness, and feasibility of microwave ablation (MWA) of small renal cell carcinomas (RCCs) in selected patients. Institutional review board and informed consent were obtained. From December 2007 to January 2009, 12 patients (8 male, 4 female) were enrolled in a treatment group, in which percutaneous MWA of small RCCs was performed under contrast-enhanced ultrasound guidance. The tumors were 1.7-2.9 cm in diameter (mean diameter, 2.0 cm).Therapeutic effects were assessed at follow-up with computed tomography. All patients were followed up for 3-14 months (mean, 6 months) to observe the therapeutic effects and complications (according to SIR classification). Assessment was carried out with CT imaging. No severe complications or unexpected side effects were observed after the MWA procedures. In all cases technical success was achieved. Clinical effectiveness was 100%; none of the patients showed recurrence on imaging. In conclusion, our preliminary results support the use of MWA for the treatment of small renal tumors. This technology can be applied in select patients who are not candidates for surgery, as an alternative to other ablative techniques.
Collapse
Affiliation(s)
- Gianpaolo Carrafiello
- Department of Radiology, University of Insubria, Viale Borri 57, Varese 21100, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
54
|
Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol 2009; 21:599-605. [PMID: 19282763 DOI: 10.1097/meg.0b013e328318ed04] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
This article reviews the therapeutic efficacy and complications of microwave ablation (MWA) in the treatment of primary and secondary liver malignancies. A PubMed search using keywords 'microwave', 'liver', 'malignancy', 'cancer' and 'tumour' was performed to identify articles related to MWA of liver malignancies published in English from 1975 to February 2008. MWA is an effective treatment options for both primary and secondary liver malignancies with survivals comparable with those of liver resections. Local recurrences can be managed with further ablation. Small tumour size, well-differentiated tumour and a reduced number of lesions are factors associated with good prognosis. Temporary occlusion of the portal venous and hepatic arterial flow may increase the size of ablation but the safety aspect requires further validation. MWA is a minimally invasive technique that has broadened the therapeutic option for patients with conventionally unresectable liver tumours with promising survival data. Future advances in the applicator design and treatment monitoring may further improve its efficacy and widen the indications.
Collapse
|
55
|
Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol 2009; 19:e22-32. [PMID: 19268571 DOI: 10.1016/j.suronc.2009.02.001] [Citation(s) in RCA: 108] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2008] [Revised: 01/12/2009] [Accepted: 02/04/2009] [Indexed: 11/17/2022]
Abstract
BACKGROUND Surgical resection of malignant hepatic tumors has been demonstrated to increase overall survival; however, the majority of patients are not candidates for resection. For patients with unresectable tumors, various chemical and thermal ablation modalities have been developed. microwave coagulation therapy (MCT) is one such thermal ablation modality and the purpose of this review is to evaluate the presently available data for MCT and assess the level of evidence to support its clinical use. METHODS This review is limited to published studies in the English literature including at least 30 patients per study with MCT for hepatocellular cancer (HCC) or colorectal hepatic metastasis (CRHM). Patterns of local recurrence, complications and survival outcome of MCT ablation are presented and discussed including assessment of Asian experience using the 2.4GHZ device and American experience using the 914MHZ device. CONCLUSIONS Although randomized controlled trials comparing RFA and MCT for hepatic ablation are lacking, our review (based on level 2 data) supports that MCT may be optimal when larger necrosis zones and/or ablation of multiple lesions are the objectives. The data support that the potential procedural advantage(s) noted for ablation of CRHM and HCC >3cm, is not supported for HCC <3cm; moreover MCT shares with all other ablation modalities a high rate of locoregional recurrence in HCC; likely due to the multicentricity of this disease process.
Collapse
Affiliation(s)
- C Boutros
- Hepatobiliary and Surgical Oncology, Roger Williams Medical Center, 825 Chalkstone Ave., Providence, RI 02908, USA
| | | | | | | | | |
Collapse
|
56
|
Yang WZ, Jiang N, Huang N, Huang JY, Zheng QB, Shen Q. Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol 2009; 15:748-52. [PMID: 19222102 PMCID: PMC2653446 DOI: 10.3748/wjg.15.748] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To assess the efficacy of combined transcatheter arterial chemoembolization (TACE) and percutaneous microwave coagulation therapy (PMCT) for small hepatocellular carcinoma (HCC).
METHODS: Thirty-five patients with a total of 41 HCC nodules (≤ 3 cm in diameter) were treated with TACE followed by computed tomograghy (CT)-guided percutaneous microwave coagulation therapy (PMCT) within 1-3 wk.
RESULTS: By biopsies and enhanced CT scans, complete necrosis of the tumor and 3-5 mm of the surrounding non-cancerous area were observed in 34 foci. In seven foci, incomplete necrosis of the surrounding parenchyma was observed. Serum alpha-fetoprotein (AFP) levels returned to normal 10 d after treatment in 25 patients who originally had high serum AFP levels. The follow-up period was 6-31 mo, and all patients remained alive. One patient had a recurrence in the subsegments of the liver, and another patient had a recurrence near the original lesion.
CONCLUSION: Combined therapy with TACE and PMCT is a safe and effective treatment without severe complications for small HCC.
Collapse
|
57
|
Comparison of ablation zone between 915- and 2,450-MHz cooled-shaft microwave antenna: results in in vivo porcine livers. AJR Am J Roentgenol 2009; 192:511-4. [PMID: 19155418 DOI: 10.2214/ajr.07.3828] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE The objective of our study was to compare the ablation zones of two cooled-shaft microwave antennae-one operating at 915 MHz and one operating at 2,450 MHz-in in vivo porcine livers. CONCLUSION The 915-MHz cooled-shaft microwave antenna can lead to deeper penetration of liver tissue and can yield a significantly larger ablation zone than the 2,450-MHz cooled-shaft antenna in in vivo porcine livers. In light of the result, 915-MHz cooled-shaft microwaves may be more effective for tumor ablation, especially for large tumors.
Collapse
|
58
|
Carrafiello G, Laganà D, Mangini M, Fontana F, Dionigi G, Boni L, Rovera F, Cuffari S, Fugazzola C. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg 2008; 6 Suppl 1:S65-9. [PMID: 19186116 DOI: 10.1016/j.ijsu.2008.12.028] [Citation(s) in RCA: 154] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Local ablative techniques have been developed to enable local control of unresectable tumors. Ablation has been performed with several modalities including ethanol ablation, laser ablation, cryoablation, and radiofrequency ablation. Microwave technology is a new thermal ablation technique for different types of tumors, providing all the benefits of radiofrequency and substantial advantages. Microwave ablation has been applied to liver, lung, kidney and more rarely to bone, pancreas and adrenal glands. Preliminary works show that microwave ablation may be a viable alternative to other ablation techniques in selected patients. However further studies are necessary to confirm short- and long-term effectiveness of the methods and to compare it with other ablative techniques, especially RF.
Collapse
|
59
|
Oshima F, Yamakado K, Nakatsuka A, Takaki H, Makita M, Takeda K. Simultaneous microwave ablation using multiple antennas in explanted bovine livers: relationship between ablative zone and antenna. ACTA ACUST UNITED AC 2008; 26:408-14. [PMID: 18769998 DOI: 10.1007/s11604-008-0251-x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2008] [Accepted: 04/11/2008] [Indexed: 12/19/2022]
Abstract
PURPOSE Our purpose was to determine the optimal antenna spacing to achieve large ablative zones without indentations when microwave ablation is performed with simultaneous activation of two or three antennas. MATERIALS AND METHODS Microwave ablation was performed with single-antenna activation and simultaneous activation of two or three antennas with a spacing of 1.5, 2.0, 2.5, or 3.0 cm in explanted bovine livers. Microwave energy was applied for 10 min with a power of 45 W. The shapes and sizes of the ablative zones created were recorded and compared. RESULTS The shape of the ablative zone was ellipsoid in the axial plane (along the antenna axis) and spherical in the transverse plane (perpendicular to the antenna axis) in single-antenna ablation. The ablative zones were spherical or ellipsoid in both the axial and transverse planes in two-and three-antenna ablation with an antenna spacing of 2.0 cm or less. Indentations were observed between the ablative zones created by the antennas when the spacing was 2.5 cm or more, reducing the minimum transverse diameter. When two-or three-antenna ablation was performed with a spacing of 2.0 cm or less, the axial and minimum transverse diameters were significantly larger than in single-antenna ablation. The largest volume (almost two or three times the single-activation volume) was achieved in two-or three-antenna ablation with an antenna spacing of 2.0 cm. CONCLUSION We found that simultaneous microwave ablation using multiple microwave antennas creates large ablative zones without indentations when multiple antennas are activated with an antenna spacing of 2.0 cm or less.
Collapse
Affiliation(s)
- Fumiyoshi Oshima
- Department of Radiology, Mie University School of Medicine, 2-174 Edobashi, Tsu, 514-8507, Japan
| | | | | | | | | | | |
Collapse
|
60
|
Gravante G, Ong SL, Metcalfe MS, Strickland A, Dennison AR, Lloyd DM. Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int 2008; 28:911-21. [PMID: 18564212 DOI: 10.1111/j.1478-3231.2008.01810.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Microwave (MW) ablation therapy is a local treatment by which tumours are destroyed by coagulation from the passage of MWs into cells. The aim of this review is to examine histological results obtained from preclinical and clinical studies. A literature search was undertaken for all studies focusing on MW therapy and in which lesions were excised for a complete histopathological examination after treatment. Two main zones were described after ablative therapy (central and transitional). Both corresponded to specific microscopic characteristics and evolved over time in a precise manner. No viable cells even up to 6 cm in diameter were demonstrated in 93% of lesions after treatment. Microwave therapy is a reliable technique under a variety of clinical situations. Future investigations are needed to compare MW with other ablative techniques to identify factors that influence the effectiveness of the various techniques and to determine specific indications.
Collapse
Affiliation(s)
- Gianpiero Gravante
- Department of Hepatobiliary and Pancreatic Surgery, University Hospitals of Leicester, Leicester, UK.
| | | | | | | | | | | |
Collapse
|
61
|
Guidelines for power and time variables for microwave ablation in an in vivo porcine kidney. J Surg Res 2008; 153:263-7. [PMID: 18486149 DOI: 10.1016/j.jss.2008.03.044] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2008] [Revised: 03/20/2008] [Accepted: 03/28/2008] [Indexed: 11/23/2022]
Abstract
PURPOSE Microwave technology provides an emerging thermal ablation technique for solid organ tumors. We propose guidelines and recommend optimal time and power for use. METHODS Microwave ablations using a VivaWave Microwave Ablation System (Valleylab, Boulder, CO) were performed in vivo in a porcine kidney model. The independent variables were power (20, 30, 40, 45, 50, 60 W) and time (2, 4, 6, 8, 10, 15, 20 min) with the outcome variable diameter of ablation. Following ablations, kidneys were procured for gross and histological evaluation. Analysis of variance (ANOVA) was used followed by Tukey tests when appropriate. A P value of <0.05 was considered statistically significant. RESULTS In 308 total ablations, a minimum of 7 ablations were performed in 35 of 42 power and time variables (83%). The outcome variable, ablation diameter, was affected significantly by time, power, and time/power interaction (P < 0.0001). For each time point, a one-way ANOVA showed an overall significant difference in ablation size X wattage (P < 0.0001). Tukey tests showed that, at each time point, ablation sizes at 45, 50, and 60 W were not significantly different. After determining that 45 W was optimal, a one-way ANOVA showed an overall significant difference in ablation sizes for time points at 45 W (P < 0.0001). Tukey tests showed that, at 45 W, ablation sizes at 10 min were significantly larger than ablation sizes at 8, 6, 4, and 2 min. CONCLUSIONS We propose guidelines for use of a novel microwave ablation system and recommend use at 45 W for 10 min.
Collapse
|
62
|
Abstract
Surgical resection is the treatment of choice in patients with colorectal liver metastases, with 5-year survival rates reported in the range of 40%-58%. Over the past 10 years, there has been an impetus to expand the criteria for defining resectability for patients with colorectal metastases. In the past, such features as the number of metastases (three to four), the size of the tumor lesion, and a mandatory 1-cm margin of resection dictated who was "resectable." More recently, the criteria for resectability have been expanded to include any patient in whom all disease can be removed with a negative margin and who has adequate hepatic volume/reserve. Specifically, instead of resectability being defined by what is removed, decisions concerning resectability now center around what will remain after resection. Under this new paradigm, the number of patients with resectable disease can be expanded by increasing/preserving hepatic reserve (e.g., portal vein embolization, two-stage hepatectomy), combining resection with ablation, and decreasing tumor size (preoperative chemotherapy). The criteria for resectability have also expanded to include patients with extrahepatic disease. Rather than being an absolute contraindication to surgery, patients with both intra- and extrahepatic disease should potentially be considered for resection based on strict selection criteria. The expansion of criteria for resectability of colorectal liver metastases requires a much more nuanced and sophisticated approach to the patient with advanced disease. A therapeutic approach that includes all aspects of multidisciplinary and multimodality care is required to select and treat this complex group of patients.
Collapse
Affiliation(s)
- Timothy M Pawlik
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 22187-6681, USA.
| | | | | |
Collapse
|
63
|
Laeseke PF, Sampson LA, Frey TM, Mukherjee R, Winter TC, Lee FT, Brace CL. Multiple-electrode radiofrequency ablation: comparison with a conventional cluster electrode in an in vivo porcine kidney model. J Vasc Interv Radiol 2008; 18:1005-10. [PMID: 17675619 DOI: 10.1016/j.jvir.2007.05.010] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE To compare multiple-electrode radiofrequency (RF) ablation versus RF ablation with a cluster electrode in an in vivo porcine kidney model. MATERIALS AND METHODS Thirteen female pigs (mean weight, 45 kg) were used for the study. In each animal, RF ablations were performed for 12 minutes with a conventional cluster electrode in one kidney (controls, n = 13) and a multiple-electrode configuration in the contralateral organ. Multiple-electrode ablations were performed with electrodes 1.5 cm apart (group 1, n = 7) or 2.0 cm apart (group 2, n = 6). The mean maximum temperature at the electrode tips was determined. After each animal was euthanized, the kidneys were removed and the ablation zones were sectioned into 5-mm transverse slices. A representative slice was stained with 2,3,5-triphenyl-2H-tetrazolium chloride. Standard ablation zone metrics were measured and differences between groups were analyzed for statistical significance. RESULTS The mean maximum ablation zone diameter was 3.0 cm +/- 0.6 (SD) for controls, compared with 5.0 cm +/- 0.5 for group 1 (P < .0001) and 4.4 cm +/- 1.0 for group 2 (P = .002). Mean ablation zone minimum diameter was higher for group 1 (P = .002) and group 2 (P = .03) than for controls. Isoperimetric ratios were lowest for group 2 (P = .04 vs controls) whereas the highest temperatures at the electrode tips were observed with group 1 (P = .02 vs controls). CONCLUSION In normal porcine kidney, multiple-electrode RF ablation produced larger zones of ablation than a cluster electrode. Efficacy was greater when electrodes were spaced 1.5 cm apart than when they were spaced 2.0 cm apart.
Collapse
Affiliation(s)
- Paul F Laeseke
- Department of Biomedical Engineering, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin 53792, USA
| | | | | | | | | | | | | |
Collapse
|
64
|
Hope WW, Schmelzer TM, Newcomb WL, Heath JJ, Lincourt AE, Norton HJ, Heniford BT, Iannitti DA. Guidelines for power and time variables for microwave ablation in a porcine liver. J Gastrointest Surg 2008; 12:463-7. [PMID: 17805939 DOI: 10.1007/s11605-007-0248-2] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2007] [Accepted: 07/16/2007] [Indexed: 01/31/2023]
Abstract
The purpose of our study was to provide guidelines for the use of a novel microwave ablation system. Microwave ablations using a 915-MHz system were evaluated in a porcine liver. The independent variables were power and time, with the outcome variable being diameter of ablation. After ablations, livers were procured for measurement and histologic evaluation. Our study consisted of 420 ablations. The outcome variable, ablation diameter, was affected significantly by time, power, and time/power interaction (p<0.0001). For each time point, a one-way analysis of variance (ANOVA) showed an overall significant difference in ablation size X wattage (p<0.0001). Tukey tests at each time point showed ablation sizes at 45, 50, and 60 W were not significantly different. After it was determined that 45 W was optimal, a one-way ANOVA showed an overall significant difference in ablation sizes for time points at 45 W (p<0.0001). Tukey tests revealed that at 45 W, ablation sizes at 10, 15, and 20 min were not statistically different. We propose guidelines for diameters based on different time and power variables and recommend 45 W for 10 min to achieve optimal diameters at the shortest time and lowest wattage.
Collapse
Affiliation(s)
- William W Hope
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical Center, Charlotte, NC, USA
| | | | | | | | | | | | | | | |
Collapse
|
65
|
Abstract
OBJECTIVE This article reviews the basic principles, equipment, current therapeutic status and future trends of microwave ablation (MWA) in the treatment of hepatocellular carcinoma (HCC). METHODS All articles published in English on MWA or MWA as a treatment for HCC were identified with a PubMed search from the 1990s through June 2007. Papers were reviewed on the technical advances of MWA equipment and the clinical applications of MWA including indications, techniques, therapeutic outcomes, complications and combination therapies. RESULTS MWA has several advantages, including high thermal efficiency, higher capability of coagulating blood vessels, faster ablation time, and an improved convention profile. MWA can induce large ablation volumes and yield good local tumor control, especially for small HCC. Larger HCC can also be completely ablated by using more effective antenna or simultaneous application of multiple antennae. Long-term survival comparable to that of surgery was obtained for tumors measuring 4 cm or less. Associated complications appear to be low. CONCLUSIONS MWA is a promising minimally invasive technique for the treatment of HCC. Future advances are warranted to improve the therapeutic efficacy.
Collapse
Affiliation(s)
- Ping Liang
- Department of Ultrasound, Chinese PLA General Hospital, Beijing, PR China.
| | | |
Collapse
|
66
|
Nicholl MB, Bilchik AJ. Thermal ablation of hepatic malignancy: useful but still not optimal. Eur J Surg Oncol 2007; 34:318-23. [PMID: 18055158 DOI: 10.1016/j.ejso.2007.07.203] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2007] [Accepted: 07/20/2007] [Indexed: 12/21/2022] Open
Abstract
The mortality associated with primary and metastatic hepatic malignancies remains high because few patients are candidates for hepatic resection or transplantation. Resection is the most effective treatment for liver tumors but may be contraindicated by factors such as the tumor's location; hepatic transplantation can cure primary hepatocellular carcinoma and underlying cirrhosis, but a donor may not be immediately available. When resection or transplantation is not possible, thermal ablation is a reasonable therapeutic option. Effective destruction of tumors can be achieved with low recurrence rates and minimal complications or risk of death. In patients with primary hepatic malignancy, ablation treatment does not preclude subsequent transplantation. Although radiofrequency ablation is currently the most widely used thermal ablative technique for hepatic malignancy, microwave ablation is gaining popularity and eventually may prove to be more effective.
Collapse
Affiliation(s)
- M B Nicholl
- Department of Gastrointestinal Surgery, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
| | | |
Collapse
|
67
|
Weinberg BD, Patel RB, Exner AA, Saidel GM, Gao J. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. J Control Release 2007; 124:11-9. [PMID: 17900740 PMCID: PMC2211420 DOI: 10.1016/j.jconrel.2007.08.023] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2007] [Revised: 08/15/2007] [Accepted: 08/16/2007] [Indexed: 12/12/2022]
Abstract
A mathematical model of drug transport provides an ideal strategy to optimize intratumoral drug delivery implants to supplement radiofrequency (RF) ablation for tumor treatment. To simulate doxorubicin transport in non-ablated and ablated liver tumors, a one-dimensional, cylindrically symmetric transport model was generated using a finite element method (FEM). Parameters of this model, the diffusion (D) and elimination (gamma) coefficients for doxorubicin, were estimated using drug distributions measured 4 and 8 days after placing biodegradable implants in non-ablated and ablated rabbit VX2 liver carcinomas. In non-ablated tumor, values of diffusion and elimination parameters were 25% and 94% lower than normal liver tissue, respectively. In ablated tumor, diffusion near the ablation center was 75% higher than non-ablated tumor but decreased to the non-ablated tumor value at the ablation periphery. Drug elimination in ablated tumor was zero for the first four days, but by day 8 returned to 98% of the value for non-ablated tumor. Three-dimensional (3-D) simulations of drug delivery from implants with and without RF thermal ablation underscore the benefit of using RF ablation to facilitate local drug distribution. This study demonstrates the use of computational modeling and optimal parameter estimation to predict local drug pharmacokinetics from intratumoral implants after ablation.
Collapse
Affiliation(s)
- Brent D. Weinberg
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
- Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390
| | - Ravi B. Patel
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
| | - Agata A. Exner
- Department of Radiology, Case Western Reserve University, Cleveland, OH 44106
| | - Gerald M. Saidel
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106
| | - Jinming Gao
- Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390
| |
Collapse
|
68
|
Radiofrequency ablation of colorectal carcinoma liver metastases. CURRENT COLORECTAL CANCER REPORTS 2007. [DOI: 10.1007/s11888-007-0008-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
69
|
Shen P, Geisinger KR, Zagoria R, Levine EA. Pathologic correlation study of microwave coagulation therapy for hepatic malignancies using a three-ring probe. J Gastrointest Surg 2007; 11:603-11. [PMID: 17393259 DOI: 10.1007/s11605-006-0046-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Microwave coagulation therapy (MCT) for the ablation of unresectable hepatic malignancies is a promising alternative to radiofrequency and cryoablation techniques. There are few data on the clinical effectiveness of MCT. In vivo pathologic evaluation of ablated tumor tissue is not well described for the three-ring microwave probe. The study design was a prospective trial enrolling patients with resectable hepatic malignancies. Lesions underwent in vivo MCT with the three-ring probe prior to liver resection. Gross and histologic evaluations of the tumor were performed, including nicotinamide adenine dinucleotide (NADH) vital staining. A total of nine patients with metastatic colon cancer were enrolled and had NADH stains performed of their pathologic specimens. The median size of the metastasis being ablated was 3.5 cm (range, 1.5-12.3). Fifty-six percent of the tumors demonstrated evidence of spontaneous coagulative necrosis on immediate histologic examination. The median dimensions of the ablation zones were 5 cm (range, 3-7) x 4.5 cm (range, 2.5-5.2) x 4.2 cm (range, 2-5) with a 5-min ablation at 60 W. The median ablation volume was 50.6 cm3 (range, 9-78). NADH vital staining was performed of the ablation zones with 100% absence of staining in the tumor tissue and in benign hepatic parenchyma, which is consistent with irreversible cellular damage. In conclusion, in vivo MCT of hepatic malignancies with the three-ring probe produces nonviable tumor cells after a 5-min ablation. The ablation time is significantly shorter than other available ablative techniques. Immediate histologic exam produces some evidence of coagulative necrosis. Further study of this promising technology is warranted.
Collapse
Affiliation(s)
- Perry Shen
- Department of General Surgery, Surgical Oncology Section, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
| | | | | | | |
Collapse
|
70
|
Iannitti DA, Martin RC, Simon CJ, Hope WW, Newcomb WL, McMasters KM, Dupuy D. Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) 2007; 9:120-4. [PMID: 18333126 PMCID: PMC2020783 DOI: 10.1080/13651820701222677] [Citation(s) in RCA: 102] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2007] [Indexed: 02/09/2023]
Abstract
BACKGROUND Thermal ablation techniques have become important treatment options for patients with unresectable hepatic malignancies. Microwave ablation (MWA) is a new thermal ablative technique that uses electromagnetic energy to produce coagulation necrosis. We report outcomes from the first clinical trial in the United States using MWA and a 915 MHz generator. PATIENTS AND METHODS Patients with unresectable primary or metastatic liver cancer were enrolled in a multi-institutional trial from March 2004 through May 2006. Demographic information, diagnosis, treatment, and outcomes were documented. RESULTS Eighty-seven patients underwent 94 ablation procedures for 224 hepatic tumors. Forty-two ablations (45%) were performed open, 7 (7%) laparoscopically, and 45 (48%) percutaneously. The average tumor size was 3.6 cm (range 0.5-9.0 cm). Single antenna ablation volumes were 10.0 ml (range 7.8-14.0 ml), and clustered antennae ablation volumes were 50.5 ml (range 21.1-146.5 ml). Outcome variables were measured with a mean follow-up of 19 months. Local recurrence at the ablation site occurred in 6 (2.7%) tumors, and regional recurrence occurred in 37 (43%) patients. With a mean follow-up of 19 months, 41 (47%) patients were alive with no evidence of disease. There were no procedure-related deaths. The overall mortality rate was 2.3%. CONCLUSIONS Microwave ablation is a safe and effective technology for hepatic tumor ablation. In our study, clustered antennae resulted in larger ablation volumes. Further studies with histological confirmation are needed to verify clinical results.
Collapse
Affiliation(s)
- David A. Iannitti
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| | | | | | - William W. Hope
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| | - William L. Newcomb
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| | | | - Damian Dupuy
- Department of Diagnostic Imaging, BrownProvidence RIUSA
| |
Collapse
|
71
|
Hope WW, Arru JM, McKee JQ, Vrochides D, Aswad B, Simon CJ, Dupuy DE, Iannitti DA. Evaluation of mulitprobe radiofrequency technology in a porcine model. HPB (Oxford) 2007; 9:363-7. [PMID: 18345320 PMCID: PMC2225514 DOI: 10.1080/13651820701611218] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2007] [Indexed: 12/12/2022]
Abstract
OBJECTIVE We evaluated two new radiofrequency devices in an in vivo porcine model. MATERIALS AND METHODS Multiprobe radiofrequency ablation (RFA) was used in a porcine model with an impedance-based algorithm in one experiment and clustered probes with and without switcher controllers in another; a Pringle maneuver was used with half of the ablations. RESULTS The impedance experiment included 13 ablations, with a mean length of 7.0 cm and width of 2.9 cm (95% CI) and an average time of 596 s. Ablation volumes were significantly larger (54.1+/-11.7 cc(3) vs 34.9+/-4.8 cc(3), p<0.05) and ablation times were significantly shorter (359 s vs 834 s, p<0.05) for the Pringle group compared with the No Pringle group, respectively. The switcher controller experiment included 34 RFAs. Diameter (mm) (51.4 vs 40.3, p<0.0001), surface area (cm(2)) (22.4 vs 16.0, p<0.0002), and volume (cc) (66.1 vs 36.9, p<0.0001) were significantly larger for the combination probes with switcher controller compared with clustered probes, respectively. Ablation volumes for the Pringle vs No Pringle groups in the combination probes were 68.0 cc vs 64.3 cc and for the clustered probes 40.1 cc vs. 33.7 cc, respectively. CONCLUSION Multiprobe ablations using RFA are promising technologies that need further study to evaluate their clinical utility.
Collapse
Affiliation(s)
- William W. Hope
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| | - Jason M. Arru
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| | - Jason Q. McKee
- Department of Surgery and Diagnostic Imaging, Brown Medical SchoolProvidence RIUSA
| | - Dennis Vrochides
- Department of Surgery and Diagnostic Imaging, Brown Medical SchoolProvidence RIUSA
| | - Bassam Aswad
- Department of Surgery and Diagnostic Imaging, Brown Medical SchoolProvidence RIUSA
| | - Caroline J. Simon
- Department of Surgery and Diagnostic Imaging, Brown Medical SchoolProvidence RIUSA
| | - Damian E. Dupuy
- Department of Surgery and Diagnostic Imaging, Brown Medical SchoolProvidence RIUSA
| | - David A. Iannitti
- Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Medical CenterCharlotte NCUSA
| |
Collapse
|